The aim of this review is to focus on immune cells and immunological mediators against Mtb, induced both preclinically and clinically by TB vaccine candidates and BCG, that have been overshadowed by a myopic focus on CD4+ T helper 1 (TH1) cells. This evidence concerns the gene CD4 and tuberculosis.